|1.||Ding, Y F: 2 articles (10/2001 - 02/2001)|
|2.||He, R R: 2 articles (10/2001 - 02/2001)|
|3.||Tune, Johnathan D: 1 article (05/2008)|
|4.||Knudson, Jarrod D: 1 article (05/2008)|
|5.||Dincer, U Deniz: 1 article (05/2008)|
|6.||Bratz, Ian N: 1 article (05/2008)|
|7.||Dick, Gregory M: 1 article (05/2008)|
|8.||Payne, Gregory A: 1 article (05/2008)|
|9.||Rogers, Paul A: 1 article (05/2008)|
|10.||Borbouse, Léna: 1 article (05/2008)|
|1.||Acute Kidney Injury (Acute Renal Failure)
10/01/1988 - "The importance of timing and duration of 8-phenyltheophylline (8-PT) administration in determining its beneficial action in glycerol-induced acute renal failure (ARF) was investigated by examining the effects of a single dose of 8-PT given immediately following (0 h) glycerol injection and at 1 and 3 h after glycerol injection. "
05/01/1986 - "8-Phenyltheophylline (8-PT)(10 mg kg-1) or its vehicle(1 ml kg-1) were administered intravenously or intraperitoneally twice daily over 48 h to rats with acute renal failure (ARF) induced by intramuscular (i.m.) injection of glycerol. "
11/01/1989 - "1. Previous studies have shown that 8-phenyltheophylline (8-PT), a non-selective antagonist at adenosine A1- and A2-receptors, can ameliorate the severity of glycerol-induced acute renal failure (ARF) in the rat. "
10/01/1987 - "The adenosine antagonist 8-phenyltheophylline (8-PT) is a diuretic in normal rats and can ameliorate glycerol-induced acute renal failure (ARF) in this species. "
05/01/1986 - "Effect of the adenosine antagonist 8-phenyltheophylline on glycerol-induced acute renal failure in the rat."
04/01/1992 - "Canine coronary vasodepressor responses to hypoxia are attenuated but not abolished by 8-phenyltheophylline."
07/01/1990 - "Hypoxia was repeated before and after 8-phenyltheophylline administration (19.5 mumol.kg-1, intravenously) in seven rabbits, or before and after vehicle injection in five rabbits (time control). "
10/01/1989 - "In the presence of continuously infused 8-phenyltheophylline, equally severe hypoxia increased coronary perfusion pressure from 112 +/- 10 to 129 +/- 13 mmHg (P less than 0.05). "
10/01/1989 - "Anesthetized randomsource mongrel dogs of either sex were instrumented to investigate the effects of 8-phenyltheophylline on changes in coronary perfusion pressure caused by systemic hypoxia under conditions of controlled constant coronary blood flow. "
10/01/1989 - "Canine coronary vasodepressor responses to hypoxia are abolished by 8-phenyltheophylline."
09/28/1992 - "8-Phenyltheophylline, an A1 receptor antagonist, exacerbated the ischemia-induced decrease. "
01/01/1991 - "Infusion of vehicle or 10 microM 8-phenyltheophylline (8-PT) was initiated 10 min before ischemia and maintained throughout reperfusion. "
11/01/1991 - "Three minutes after the onset of ischemia, before further reduction of coronary flow, the microscopic examination revealed the existence of thromboembolization in the small coronary arteries, and the number of platelets in the regional coronary venous blood were significantly decreased, indicating that a further reduction of coronary flow due to treatment with 8-phenyltheophylline is attributed to thromboembolism caused by platelet aggregations. "
10/01/2001 - "(2) Administration of 8-phenyltheophylline (8-PT), an adenosine receptor antagonist, did not affect the discharge rate of PGL neurons, but could partially inhibit the effects of renal ischemia in 17 units (P < 0.05). "
03/01/1995 - "A control group (Control) was compared with two other groups in which adenosine receptors were blocked by 8-phenyltheophylline (7.5 mg/kg) before reperfusion (8-PT-R) or before ischemia (8-PT-I). "
11/01/1998 - "Administration of 8-phenyltheophylline, a nonselective antagonist of adenosine receptors, reduced the functional hyperemia response within the left external iliac artery by 32% and reduced the "steal" from the vascular bed perfused by the right femoral artery by 21%."
06/01/1998 - "Seven animals were pretreated with the nonspecific adenosine receptor blocker 8-phenyltheophylline (8-PT; 5 mg/kg), which decreased reactive hyperemia by an average of 38%. "
01/01/1993 - "8-Phenyltheophylline infusion attenuated functional hyperemia by approximately 40%, enhanced the fall in [PCr]/[Pi], and potentiated elevations in transudate and venous adenosine. "
10/01/1992 - "The LAD was occluded for 20 or 30 seconds and then released, and reactive hyperemia was observed before and after 8-phenyltheophylline (7.5 mg/kg i.v.) or glibenclamide (200 micrograms/kg into the LAD) infusion. "
09/01/1992 - "Adenosine release during reperfusion was augmented (22.7 +/- 1.9 nmol.100 g-1.min-1, p less than 0.001), and 8-phenyltheophylline completely abolished the enhanced reactive hyperemia. "
|6.||Purinergic P1 Receptors (Adenosine Receptor)
|7.||Adenosine A1 Receptor
|8.||Purinergic P1 Receptor Antagonists
|10.||Nitroarginine (NG Nitro L Arginine)